[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611850":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":10,"centralContacts":26,"locations":34,"responsibleParty":48,"collaborators":10,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":68,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Red Rock Regeneration Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cervical Interbody Fusion with NMP",null,"Subject has undergone cervical interbody spine fusion between C2 and T1 where NMP fibers have been used as a bone void filler with minimum of 90-day post-operative follow up data available",[13,14],"Biological: Natural Matrix Protein (NMP) Fibers","Procedure: Cervical interbody fusion",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"BIOLOGICAL","Natural Matrix Protein (NMP) Fibers","Human bone allograft",[9],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":10},"PROCEDURE","Cervical interbody fusion","Procedure that involves removing the intervertebral disk from the disk space between between 2 or more vertebrae between C2 and T1. When the disk space has been cleared out, the surgeon fills the void between the vertebrae with a bone void filler.",[9],[27,32],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Sean A Peel, PhD","CONTACT","416-898-9724","sean.peel@redrockregen.com",{"name":33,"role":29,"phone":10,"phoneExt":10,"email":10},"Mark A Prevost II, MD",[35],{"facility":36,"status":10,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":10},"Alabama Back Institute","Jasper","Alabama","35501","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-87.27751,33.83122,{"lat":46,"lon":45},{"type":49,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100611850","assessing-safety-of-cervical-spine-fusion-with-nmp-100611850",false,"NCT07245940","Assessing Safety of Cervical Spine Fusion With NMP®","Assessing Safety of Cervical Spine Fusion With NMP® Graft Material: A Retrospective Chart Review","Inclusion Criteria:\n\n1. Patients treated with NMP® for Cervical (C2-T1) Interbody fusion (2022-2025) at the study site.\n2. Minimum of 90-day post-operative follow up data available\n\nExclusion Criteria:\n\n* Patients with no follow-up data within 3 months from the surgery date due to missed postoperative appointments.","ALL","18 Years",{"count":60,"type":61},300,"ESTIMATED","OBSERVATIONAL","The goal of this retrospective chart review study is to assess safety of NMP® in the treatment of cervical spine degenerative conditions by assessing the incidence and nature of AEs in follow-up (minimum of 90 days and up to 2 year post-operatively) as well as reoperation rates.",[65,66,67],"Degenerative Disc Disease","Degenerative Spondylolisthesis","Spinal Stenosis Cervical","NOT_YET_RECRUITING","2025-11-17",{"date":71,"type":72},"2025-11-24","ACTUAL",{"date":74,"type":61},"2026-01-15",{"date":76,"type":61},"2026-08-01",{"name":5,"class":6},1]